LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma.

Wang, Shan; Chen, Zhaoxin; Lv, Hongwei; Wang, Cong; Wei, Huamin; Yu, Jing

Wang, Shan; Chen, Zhaoxin; Lv, Hongwei; Wang, Cong; Wei, Huamin; Yu, Jing.

Afiliação

Wang S; Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Chen Z; Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Lv H; Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Wang C; Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Wei H; Department of Traditional Chinese Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Yu J; Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

J Clin Lab Anal ; 37(1): e24824, 2023 Jan.

Article em En | MEDLINE | ID: mdl-36572999

Assuntos

Adenocarcinoma de Pulmão; Adenocarcinoma; Neoplasias Pulmonares; Humanos; Feminino; Prognóstico; Adenocarcinoma de Pulmão/genética; Adenocarcinoma/genética; Lipase; Neoplasias Pulmonares/genética; Biomarcadores Tumorais/genética; Microambiente Tumoral

Palavras-chave

LIPG; biomarker; immune checkpoint blocker; immune infiltrates; lung adenocarcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: J Clin Lab Anal Assunto da revista: TECNICAS E PROCEDIMENTOS DE LABORATORIO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google